Vimentin Mouse Monoclonal Antibody [D4-B11]
Catalog# EM0401
Vimentin Mouse Monoclonal Antibody [D4-B11]
-
WB
-
IF-Cell
-
IHC-P
-
FC
-
IF-Tissue
-
IHC-Fr
-
IP
-
Human
-
Mouse
-
Rat
Overview
Product Name
Vimentin Mouse Monoclonal Antibody [D4-B11]
Antibody Type
Mouse Monoclonal Antibody
Immunogen
Synthetic peptide within C-terminal human Vimentin.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IHC-P, FC, IF-Tissue, IHC-Fr, IP
Molecular Weight
Predicted band size: 54 kDa
Positive Control
HeLa cell lysate, C2C12 cell lysate, C6 cell lysate, NIH/3T3 cell lysate, Mouse embryonic stem cell lysate, Hela, human kidney tissue, human colon carcinoma tissue, human stomach carcinoma tissue, human tonsil tissue, human skin tissue, human liver tissue, human appendix tissue, human endometrium tissue.
Conjugation
unconjugated
Clone Number
D4-B11
RRID
Product Features
Form
Liquid
Concentration
2ug/ul
Storage Instructions
Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
Storage Buffer
1*PBS (pH7.4), 0.2% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG1
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000-1:10,000
-
IF-Cell
-
1:200
-
IHC-P
-
1:500-1:1,000
-
FC
-
1:500-1:1,000
-
IF-Tissue
-
1:200-1:500
-
IHC-Fr
-
1:100
-
IP
-
Use at an assay dependent concentration
Applications in Publications
Species in Publications
Human | See 8 publications below |
Mouse | See 7 publications below |
Rat | See 1 publications below |
Target
Function
Vimentin is a structural protein that in humans is encoded by the VIM gene. Its name comes from the Latin vimentum which refers to an array of flexible rods. Vimentin is a type III intermediate filament (IF) protein that is expressed in mesenchymal cells. IF proteins are found in all animal cells[6] as well as bacteria. Intermediate filaments, along with tubulin-based microtubules and actin-based microfilaments, comprises the cytoskeleton. All IF proteins are expressed in a highly developmentally-regulated fashion; vimentin is the major cytoskeletal component of mesenchymal cells. Because of this, vimentin is often used as a marker of mesenchymally-derived cells or cells undergoing an epithelial-to-mesenchymal transition (EMT) during both normal development and metastatic progression. Vimentin plays a significant role in supporting and anchoring the position of the organelles in the cytosol. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally.
Background References
1. "Aurora-B regulates the cleavage furrow-specific vimentin phosphorylation in the cytokinetic process." Goto H., Yasui Y., Kawajiri A., Nigg E.A., Terada Y., Tatsuka M., Nagata K., Inagaki M. J. Biol. Chem. 278:8526-8530(2003)
2. "Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments." Eriksson J.E., He T., Trejo-Skalli A.V., Harmala-Brasken A.-S., Hellman J., Chou Y.-H., Goldman R.D. J. Cell Sci. 117:919-932(2004)
3. "The cellular distribution of serotonin transporter is impeded on serotonin-altered vimentin network." Ahmed B.A., Bukhari I.A., Jeffus B.C., Harney J.T., Thyparambil S., Ziu E., Fraer M., Rusch N.J., Zimniak P., Lupashin V., Tang D., Kilic F. PLoS ONE 4:E4730-E4730(2009)
Sequence Similarity
Belongs to the intermediate filament family.
Tissue Specificity
Highly expressed in fibroblasts, some expression in T- and B-lymphocytes, and little or no expression in Burkitt's lymphoma cell lines. Expressed in many hormone-independent mammary carcinoma cell lines.
Post-translational Modification
Filament disassembly during mitosis is promoted by phosphorylation at Ser-55 as well as by nestin (By similarity). One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. Phosphorylation by PKN1 inhibits the formation of filaments. Phosphorylated at Ser-56 by CDK5 during neutrophil secretion in the cytoplasm. Phosphorylated by STK33. Phosphorylated on tyrosine residues by SRMS.; O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status.; S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex.
Subcellular Location
Cytoplasm
Synonyms
CTRCT30 antibody
Epididymis luminal protein 113 antibody
FLJ36605 antibody
HEL113 antibody
VIM antibody
VIME_HUMAN antibody
Vimentin antibody
Images
-
☑ Knockout (KO)
Western blot analysis of Vimentin with anti-Vimentin antibody [D4-B11] (EM0401) at 1/5,000 dilution.
Lane 1: Wild-type Hela whole cell lysate (20 µg).
Lane 2: Vimentin knockout Hela whole cell lysate (20 µg).
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (EM0401, 1/5,000) and Loading control antibody (Rabbit anti-GAPDH , ET1601-4, 1/10,000) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Mouse IgG-HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of Vimentin on different lysates with Mouse anti-Vimentin antibody (EM0401) at 1/5,000 dilution.
Lane 1: 293T cell lysate
Lane 2: HeLa cell lysate
Lane 3: Jurkat cell lysate
Lane 4: C2C12 cell lysate
Lane 5: NIH/3T3 cell lysate
Lane 6: C6 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 54 kDa
Observed band size: 54 kDa
Exposure time:15 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (EM0401) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Mouse IgG - HRP Secondary Antibody (HA1006) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunofluorescence analysis of paraffin-embedded human kidney tissue labeling Vimentin (EM0401) and NPHS2 (ET7107-34).
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Vimentin (EM0401, green) at 1/400 dilution and NPHS2 (ET7107-34, red) at 1/100 dilution overnight at 4 ℃, washed with PBS.
iFluor™ 488 conjugate-Goat anti-Mouse IgG (HA1125) and iFluor™ 594 conjugate-Goat anti-Rabbit IgG (HA1122) were used as the secondary antibodies at 1/1,000 dilution. DAPI was used as nuclear counterstain. -
Immunofluorescence analysis of paraffin-embedded human tonsil tissue labeling Vimentin (EM0401) at 1/200 dilution and Cytokeratin 5 (ET1610-43) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Vimentin (EM0401, green) at 1/200 dilution and Cytokeratin 5 (ET1610-43, red) at 1/200 dilution at +4℃ overnight, washed with PBS. Alexa Fluor®488 conjugate-Goat anti-Mouse IgG and Alexa Fluor®594 conjugate-Goat anti-Rabbit IgG were used as the secondary antibodies at 1/1,000 dilution. DAPI was used as nuclear counterstain. -
Immunofluorescence analysis of paraffin-embedded human skin tissue labeling Vimentin (EM0401) at 1/200 dilution and Cytokeratin 5 (ET1610-43) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 10% negative goat serum for 1 hour at room temperature, washed with PBS. And then probed with the primary antibodies Vimentin (EM0401, green) at 1/200 dilution and Cytokeratin 5 (ET1610-43, red) at 1/200 dilution at +4℃ overnight, washed with PBS. Alexa Fluor®488 conjugate-Goat anti-Mouse IgG and Alexa Fluor®594 conjugate-Goat anti-Rabbit IgG were used as the secondary antibodies at 1/1,000 dilution. DAPI was used as nuclear counterstain. -
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue using anti-Vimentin antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401, 1/800) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human stomach carcinoma tissue with Mouse anti-Vimentin antibody (EM0401) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human liver tissue with Mouse anti-Vimentin antibody (EM0401) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human appendix tissue with Mouse anti-Vimentin antibody (EM0401) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Mouse anti-Vimentin antibody (EM0401) at 1/2,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/2,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human endometrium tissue with Mouse anti-Vimentin antibody (EM0401) at 1/500 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/500 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse kidney tissue with Mouse anti-Vimentin antibody (EM0401) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat colon tissue with Mouse anti-Vimentin antibody (EM0401) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (EM0401) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Vimentin was immunoprecipitated from 0.2 mg HeLa cell lysate with EM0401 at 2 µg/25 µl agarose. Western blot was performed from the immunoprecipitate using EM0401 at 1/1,000 dilution. Anti-Mouse IgG for IP Nano-secondary antibody (NBI02H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: HeLa cell lysate (input)
Lane 2: EM0401 IP in HeLa cell lysate
Lane 3: Mouse IgG instead of EM0401 in HeLa cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 3 minutes; ECL: K1801 -
Immunofluorescence analysis of frozen mouse cerebral cortex tissue labeling Vimentin with Mouse anti-Vimentin antibody (EM0401).
The tissues were blocked in 3% BSA for 30 minutes at room temperature, washed with PBS, and then probed with the primary antibody (EM0401, green) at 1/100 dilution overnight at 4℃, washed with PBS. Goat Anti-Mouse IgG H&L (Alexa Fluor® 488) was used as the secondary antibody at 1/200 dilution. Nuclei were counterstained with DAPI (blue). Image acquisition was performed with KFBIO KF-FL-400 Scanner. -
Immunocytochemistry analysis of HeLa cells labeling Vimentin with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C2C12 cells labeling Vimentin with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling Vimentin with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Mouse anti-Vimentin antibody (EM0401) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Mouse IgG H&L (iFluor™ 488, HA1125) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
beta Tubulin (ET1602-4, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Rabbit IgG H&L (iFluor™ 594, HA1122) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of Hela cells labeling Vimentin.
Cells were fixed and permeabilized.Then stained with the primary antibody (EM0401, 1ug/ml) (red) compared with Mouse IgG1 Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Mouse IgG Secondary antibody (HA1125) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Fractionated irradiation induces radioresistant oral carcinoma cells with enhanced malignant phenotypes
Author: Liu Yangfan,et al
PMID: NO PMID20240504
Journal: Archives Of Oral Biology
Application: WB
Reactivity: Human
Publish date: 2024 May
-
Citation
-
RGS10 deficiency facilitates distant metastasis by inducing epithelial-mesenchymal transition in breast cancer
Author: Liu Yang,et al
PMID: no pmid240305
Journal: Preprint And Has Not Been Certified By Peer Review
Application: WB,IHC,IF
Reactivity: Mouse
Publish date: 2024 Mar
-
Citation
-
A nano-platform combats the "attack" and "defense" of cytoskeleton to block cascading tumor metastasis
Author: Tao Jing,et al
PMID: 38301926
Journal: Journal Of Controlled Release
Application: WB
Reactivity: Mouse
Publish date: 2024 Mar
-
Citation
-
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
Author: Minglu Zhou,et al
PMID: 38553476
Journal: Nature Communications
Application: IF
Reactivity: Mouse
Publish date: 2024 Mar
-
Citation
-
Deubiquitinase MYSM1 promotes doxorubicin-induced cardiotoxicity by mediating TRIM21-ferroptosis axis in cardiomyocytes
Author: Shi Xiaowen, Xu Jianjiang, Zhong Xin, Qian Yuanyuan, Lin Liming, Fang Zimin, Ye Bozhi, Lyu Yiting, Zhang Ran, Zheng Zhanxiong, Han Jibo
PMID: 39695708
Journal: Cell Communication And Signaling
Application: IF
Reactivity: Mouse
Publish date: 2024 Dec
-
Citation
-
Angiotension II directly bind P2X7 receptor to induce myocardial ferroptosis and remodeling by activating human antigen R
Author: Zhong Xin,et al
PMID: no pmid0509
Journal: Redox Biology
Application: IF
Reactivity: Mouse
Publish date: 2024 Apr
-
Citation
-
Integrative multi-omics and drug-response characterization of patient-derived prostate cancer primary cells
Author: Wang, Z., Li, Y., Zhao, W., Jiang, S., Huang, Y., Hou, J., Zhang, X., Zhai, Z., Yang, C., Wang, J., Zhu, J., Pan, J., Jiang, W., Li, Z., Ye, M., Tan, M., Jiang, H., & Dang, Y.
PMID: 37121942
Journal: Signal Transduction And Targeted Therapy
Application: WB
Reactivity: Human
Publish date: 2023 May
-
Citation
-
TRPM2 protects against cisplatin-induced acute kidney injury and mitochondrial dysfunction via modulating autophagy
Author:
PMID: 37649595
Journal: Theranostics
Application: IF-Cell
Reactivity: Mouse
Publish date: 2023 Jul
-
Citation
-
Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes
Author: Han Jibo, Fang Zimin, Han Bingjiang, Ye Bozhi, Lin Wante, Jiang Yucheng, Han Xue, Wang Xu, Wu Gaojun, Wang Yi, Liang Guang
PMID: 39195964
Journal: Nature Cardiovascular Research
Application: IHC
Reactivity: Mouse
Publish date: 2023 Aug
-
Citation
-
SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma
Author: He, X., Ma, Y., Huang, Z., Wang, G., Wang, W., Zhang, R., Guo, G., Zhang, X., Wen, Y., & Zhang, L.
PMID: 37424293
Journal: Thoracic Cancer
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
Citation
-
Sclareol attenuates liver fibrosis through SENP1‐mediated VEGFR2 SUMOylation and inhibition of downstream STAT3 signaling
Author:
PMID: 37132081
Journal: Phytotherapy Research
Application: WB
Reactivity: Rat
Publish date: 2023
-
Citation
-
Canonical and noncanonical pyroptosis are both activated in periodontal inflammation and bone resorption
Author: Rui Zhang, Zhiwu Wu, Mingming Li, Jin Yang, Ran Cheng, Tao Hu
PMID: 36146901
Journal: Journal Of Periodontal Research
Application: IF
Reactivity: Human
Publish date: 2022 Sept
-
Citation
-
CD166-specific CAR-T cells potently target colorectal cancer cells
Author: He, S., Li, S., Guo, J., Zeng, X., Liang, D., Zhu, Y., Li, Y., Yang, D., & Zhao, X.
PMID: 36327697
Journal: Translational Oncology
Application: WB
Reactivity: Human
Publish date: 2022 Oct
-
Citation
-
Mitophagy induced by UMI-77 preserves mitochondrial fitness in renal tubular epithelial cells and alleviates renal fibrosis
Author: Jin, L., Yu, B., Liu, G., Nie, W., Wang, J., Chen, J., Xiao, L., Xia, H., Han, F., & Yang, Y.
PMID: 35524750
Journal: FASEB Journal
Application: WB
Reactivity: Human
Publish date: 2022 Jun
-
Citation
-
miR-203 inhibits cell proliferation and ERK pathway in prostate cancer by targeting IRS-1. BMC cancer, 20(1), 1028.
Author: Meng, Y., Hu, X., Li, S., Zeng, X., Qiu, L., Wei, M., Wang, Z., & Han, J.
PMID: 33109107
Journal: BMC Cancer
Application: WB
Reactivity: Human
Publish date: 2020 Oct
-
Citation
-
Long term exposure to γ‑rays induces radioresistance and enhances the migration ability of bladder cancer cells
Author: Guangmin Mao, Ye Yao, Zhaolu Kong
PMID: 30365074
Journal: Molecular Medicine Reports
Application: WB
Reactivity: Human
Publish date: 2018 Oct
-
Citation
Products with the same target and pathway
Vimentin Recombinant Rabbit Monoclonal Antibody [PDH0-01]
Application: WB,IHC-P,IF-Cell,FC,IF-Tissue,mIHC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 647 Conjugated Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 647
Vimentin Recombinant Rabbit Monoclonal Antibody
Application: mIHC
Reactivity: Human
Conjugate: unconjugated
Phospho-Vimentin (S39) Recombinant Rabbit Monoclonal Antibody [JE43-26]
Application: WB,IF-Cell
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 488 Conjugated Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 488
Vimentin Recombinant Mouse Monoclonal Antibody [A6-C1-R]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Mouse Monoclonal Antibody [A6-C1]
Application: WB,IF-Cell,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Vimentin Recombinant Rabbit Monoclonal Antibody [SC60-05]
Application: WB,IHC-P,IHC-Fr,IF-Tissue,IF-Cell,FC,IP
Reactivity: Human,Mouse,Rat,Cynomolgus monkey,Pig
Conjugate: unconjugated
